Zobrazeno 1 - 10
of 2 930
pro vyhledávání: '"K. Sa"'
Autor:
Jason K. Sa, Jihye Kim, Sokbom Kang, Sang Wun Kim, Taejong Song, Seung‐Hyuk Shim, Min Chul Choi, Jae Hong No, Jae‐Yun Song, Deokhoon Kim, Yong‐Man Kim, Jae‐Hoon Kim, Jeong‐Won Lee
Publikováno v:
International Journal of Cancer. 151:1086-1097
Through the wide adaptation of next-generation sequencing (NGS) technology within clinical practice, molecular profiling of the tumor has been the principal component of personalized treatment. In our study, we have generated a large collection of ca
Autor:
Yeul Hong Kim, Jason K. Sa, Sukwon Kim, Dayoung Yoon, Byunghyun Jang, Hee-Joon Chung, Jae Sook Sung, Soohyeon Lee, Yoon Ji Choi, Ju Won Kim, Ah-Reum Lim, Jung Yoon Choi, Kyong Hwa Park
Supplementary Figure from Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af798744f7918d230093f2e1d60fb60a
https://doi.org/10.1158/2159-8290.22540960.v1
https://doi.org/10.1158/2159-8290.22540960.v1
Autor:
Yeul Hong Kim, Jason K. Sa, Sukwon Kim, Dayoung Yoon, Byunghyun Jang, Hee-Joon Chung, Jae Sook Sung, Soohyeon Lee, Yoon Ji Choi, Ju Won Kim, Ah-Reum Lim, Jung Yoon Choi, Kyong Hwa Park
Supplementary Table from Genomic Landscape and Clinical Utility in Korean Advanced Pan-Cancer Patients from Prospective Clinical Sequencing: K-MASTER Program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22f596e07c3f26bd589868b4070aad9b
https://doi.org/10.1158/2159-8290.22540954.v1
https://doi.org/10.1158/2159-8290.22540954.v1
Autor:
Yeul Hong Kim, Jason K. Sa, Sukwon Kim, Dayoung Yoon, Byunghyun Jang, Hee-Joon Chung, Jae Sook Sung, Soohyeon Lee, Yoon Ji Choi, Ju Won Kim, Ah-Reum Lim, Jung Yoon Choi, Kyong Hwa Park
The fundamental principle of precision oncology is centralized on the identification of therapeutically exploitable targets that provides individual patients with cancer an opportunity to make informed decisions on a personalized level. To facilitate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888b6de21c863a44c3c88307bda2c98f
https://doi.org/10.1158/2159-8290.c.6549520.v1
https://doi.org/10.1158/2159-8290.c.6549520.v1
Autor:
Se Hoon Park, Ghee Young Kwon, Han Yong Choi, Byong Chang Jeong, Hyun Hwan Sung, Catherine Scholz, Antonio Gualberto, Jason K. Sa, Hye Won Lee
Purpose:To assess the antitumor activity and safety of tipifarnib, a highly potent and selective farnesyltransferase inhibitor, we performed a phase II clinical trial in patients with advanced and refractory urothelial carcinoma harboring missense HR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d76ae575bf86a6164763cf8c8d18f31
https://doi.org/10.1158/1078-0432.c.6529772.v1
https://doi.org/10.1158/1078-0432.c.6529772.v1
Autor:
Se Hoon Park, Ghee Young Kwon, Han Yong Choi, Byong Chang Jeong, Hyun Hwan Sung, Catherine Scholz, Antonio Gualberto, Jason K. Sa, Hye Won Lee
Comparison of the somatic mutational landscape in our patient population with The Cancer Genome Atlas (TCGA) data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312c1114af4c0d6770039026015d53ac
https://doi.org/10.1158/1078-0432.22477844
https://doi.org/10.1158/1078-0432.22477844
Autor:
Se Hoon Park, Ghee Young Kwon, Han Yong Choi, Byong Chang Jeong, Hyun Hwan Sung, Catherine Scholz, Antonio Gualberto, Jason K. Sa, Hye Won Lee
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f28f5e70689980ae76d613825012db
https://doi.org/10.1158/1078-0432.22477838
https://doi.org/10.1158/1078-0432.22477838
Autor:
Jong Bae Park, Myung-Jin Park, Do-Hyun Nam, Soo-Youl Kim, Jong Heon Kim, Jeongwu Lee, Seung-Hoon Lee, Heon Yoo, Ho-Shin Gwak, Ichiro Nakano, Weiwei Lin, Saewhan Park, Hyung Joon Kwon, Jeong Cheol Kim, Jason K. Sa, Hee Jin Cho, Nakho Chang, Jun Hee Hong, Tae Hoon Kim, Eunji Choi, Sung Soo Kim, Jeong-Yub Kim, Young Taek Oh, Jinlong Yin
Necrosis is a hallmark of glioblastoma (GBM) and is responsible for poor prognosis and resistance to conventional therapies. However, the molecular mechanisms underlying necrotic microenvironment-induced malignancy of GBM have not been elucidated. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d037f5975a3d97d85187473bb23fc31
https://doi.org/10.1158/0008-5472.c.6509225.v1
https://doi.org/10.1158/0008-5472.c.6509225.v1
Autor:
Se Hoon Park, Ghee Young Kwon, Han Yong Choi, Byong Chang Jeong, Hyun Hwan Sung, Catherine Scholz, Antonio Gualberto, Jason K. Sa, Hye Won Lee
Heatmap showing genomic biomarkers found in all genetically screened patients (n = 224)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9192b282a193b82c1baa7b4827f8a880
https://doi.org/10.1158/1078-0432.22477847.v1
https://doi.org/10.1158/1078-0432.22477847.v1
Autor:
Jong Bae Park, Myung-Jin Park, Do-Hyun Nam, Soo-Youl Kim, Jong Heon Kim, Jeongwu Lee, Seung-Hoon Lee, Heon Yoo, Ho-Shin Gwak, Ichiro Nakano, Weiwei Lin, Saewhan Park, Hyung Joon Kwon, Jeong Cheol Kim, Jason K. Sa, Hee Jin Cho, Nakho Chang, Jun Hee Hong, Tae Hoon Kim, Eunji Choi, Sung Soo Kim, Jeong-Yub Kim, Young Taek Oh, Jinlong Yin
Supplementary Figure 1 related to Figure 1. TGM2 is highly expressed in the necrotic region of MES GBM. Supplementary Figure 2 related to Figure 2. TGM2 regulates stemness of MES, PN, and CL GSCs. Supplementary Figure 3 related to Figure 4. A negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c4f6bc1fbb44057ee31a2fee51a6f4
https://doi.org/10.1158/0008-5472.22415315
https://doi.org/10.1158/0008-5472.22415315